Jacob Gottlieb is back to creating innovative concepts and opportunities. He is joining forces with an old friend Stuart Weisbrod. Weisbrod was a mentor to Jacob when they were both at Merlin Biomed Group. Weisbrod is a co-founder of Merlin and used Gottlieb as his portfolio manager in 2000. Gottlieb respects Weisbrod and credits him with his knowledge about the industry. Jacob Gottlieb was a tremendous asset to Merlin and brought several high level clients to the company before it closed for business in 2007.
Jacob Gottlieb went on to form Visium Asset Management. Visium was started with a 300 million dollar investment that quickly rose to 2.5 billion. The company thrived during the 2008 financial crisis. At this point it had built its value up to an 8 billion dollar hedge fund. There were offices in New York, San Francisco and New York City. The employee ranks featured an international staff of well over 200 personnel.
Visium continued its run for 10 years until several of its top executives were accused of insider trading. The information was gathered by the FBI, who was working with an informant inside the company. They brought formal charges to a number of the company’s highest ranking team members. However, Jacob Gottlieb was never accused of any wrongdoing. Jacob Gottlieb stayed on with Visium and saw the company through its investigation. He remained the CEO and dedicated himself to returning funds to investors.
Jacob Gottlieb has put his time into developing a new enterprises. He has recently launched Altium Capital. Altium Capital is a hedge fund that will focus in Gottlieb’s primary specialty, healthcare. The organization already has a stake in Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals Inc is on the cutting edge of healthcare and will save millions of lives in the future.